Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Mechanism of platelet activating factor-induced vascular leakage in the rat trachea.

Kirsch CM, Brokaw JJ, Prow DM, White GW.

Exp Lung Res. 1992 Jul-Aug;18(4):447-59.

PMID:
1355425
3.

Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.

Evans TW, Chung KF, Rogers DF, Barnes PJ.

J Appl Physiol (1985). 1987 Aug;63(2):479-84.

PMID:
3115939
4.

Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediators.

Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J.

J Lipid Mediat Cell Signal. 1997 Sep;17(1):31-45.

PMID:
9302653
5.

Nitric oxide mediates platelet activating factor-induced microvascular leakage in rat airways.

Jeon SY, Kim EA, Ma YW, Kim JP, Jung TG, Hwang EG.

Ann Otol Rhinol Laryngol. 2001 Jan;110(1):83-6.

PMID:
11201815
6.

Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney.

Perico N, Delaini F, Tagliaferri M, Abbate M, Cucchi M, Bertani T, Remuzzi G.

Lab Invest. 1988 Feb;58(2):163-71.

PMID:
3123798
7.
8.

Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.

Kaneko T, Ikeda H, Fu L, Nishiyama H, Okubo T.

Eur J Pharmacol. 1995 Mar 16;292(3-4):251-5.

PMID:
7796863
9.
10.

Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.

Sirois MG, de Lima WT, de Brum Fernandes AJ, Johnson RJ, Plante GE, Sirois P.

Br J Pharmacol. 1994 Apr;111(4):1111-6.

11.

Studies on the mechanism of PAF-induced vasopermeability in rat lungs.

de Lima WT, Kwasniewski FH, Sirois P, Jancar S.

Prostaglandins Leukot Essent Fatty Acids. 1995 Apr;52(4):245-9.

PMID:
7784472
12.

Role of PAF in the late airway microvascular leakage induced by antigen in IgE-sensitized rat.

Kyriacopoulos F, Boichot E, Lagente V, Mencia-Huerta JM, Braquet P.

Fundam Clin Pharmacol. 1995;9(4):350-6.

PMID:
8566934
14.
15.

Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi.

O'Donnell SR, Barnett CJ.

Eur J Pharmacol. 1987 Jun 26;138(3):385-96.

PMID:
3040440
16.

Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow.

Corfield DR, Webber SE, Widdicombe JG.

Br J Pharmacol. 1991 Jul;103(3):1740-4.

17.

A new NK1 receptor antagonist (CP-99,994) prevents the increase in tracheal vascular permeability produced by hypertonic saline.

Piedimonte G, Bertrand C, Geppetti P, Snider RM, Desai MC, Nadel JA.

J Pharmacol Exp Ther. 1993 Jul;266(1):270-3.

PMID:
7687291
18.
19.

Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig.

Evans TW, Rogers DF, Aursudkij B, Chung KF, Barnes PJ.

Clin Sci (Lond). 1989 May;76(5):479-85.

PMID:
2721114
20.

Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.

Balsa D, Merlos M, Giral M, Ferrando R, Garcia-Rafanell J, Forn J.

Drugs Exp Clin Res. 1997;23(5-6):191-9.

PMID:
9515229

Supplemental Content

Support Center